Crinetics Pharmaceuticals, Inc.
CRNXDelisted Sep 1, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001658247
Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.
Holders of 5% or more of CRNX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Crinetics Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 13G/A | 15.00%14.0M shares | +4.60 ppfrom 10.40% | Feb 7, 20253 filings | May 12, 2025 | SEC |
| Wellington Management Group LLP | 13G/A | 8.90%8.38M shares | +2.70 ppfrom 6.20% | Feb 10, 20253 filings | Nov 12, 2025 | SEC |
| Farallon Capital Partners, L.P. | 13G/A | 8.50%8.02M shares | +2.50 ppfrom 6.00% | Sep 8, 20252 filings | Feb 5, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
11 Schedule 13D and 13G filings on Crinetics Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 13, 20264:11 PM ET | Wellington Management Group LLPand 3 others | 13G/A | 6.80%7.13M shares | −1.00 ppfrom 7.80% | Jun 30, 2026 | SEC |
| Aug 7, 202611:04 AM ET | FMR LLCand 1 other | 13G/A | 1.40%1.44M shares | −13.60 ppfrom 15.00%Below 5% | Jul 31, 2026 | SEC |
| Aug 3, 20268:29 AM ET | Farallon Capital Management, L.L.C.and 28 others | 13G/A | 8.50%8.99M shares | – | Jun 30, 2026 | SEC |
| May 15, 202610:07 AM ET | Price T Rowe Associates Inc | 13G/A | 5.10%5.36M shares | – | Mar 31, 2026 | SEC |
| May 15, 20267:34 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 7.80%8.16M shares | −1.10 ppfrom 8.90% | Mar 31, 2026 | SEC |
| May 15, 20267:08 AM ET | Driehaus Capital Management LLC | 13G/A | 6.11%6.40M shares | – | Mar 31, 2026 | SEC |
| Apr 29, 20265:37 PM ET | Vanguard Capital Management LLC | 13G | 5.19%5.44M shares | New | Mar 31, 2026 | SEC |
| Mar 26, 20265:40 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −10.00 ppfrom 10.00%Below 5% | Mar 13, 2026 | SEC |
| Feb 5, 20262:45 PM ET | Farallon Capital Partners, L.P.and 30 others | 13G/A | 8.50%8.02M shares | +2.50 ppfrom 6.00% | Dec 31, 2025 | SEC |
| Nov 12, 20259:33 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 8.90%8.38M shares | +2.70 ppfrom 6.20% | Sep 30, 2025 | SEC |
| Sep 8, 20255:36 PM ET | Farallon Capital Partners, L.P.and 29 others | 13G | 6.00%5.63M shares | New | Aug 29, 2025 | SEC |
| Aug 12, 202510:34 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 6.20%5.81M shares | −1.30 ppfrom 7.50% | Jun 30, 2025 | SEC |
| May 12, 202510:28 AM ET | FMR LLCand 1 other | 13G/A | 15.00%14.0M shares | +4.60 ppfrom 10.40% | Mar 31, 2025 | SEC |
| Apr 7, 202511:52 AM ET | Vanguard Group Inc | 13G/A | 10.00%9.31M shares | +0.20 ppfrom 9.80% | Mar 31, 2025 | SEC |
| Feb 10, 202510:25 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 7.50%6.95M shares | – | Dec 31, 2024 | SEC |
| Feb 7, 202510:23 AM ET | FMR LLCand 1 other | 13G/A | 10.40%9.63M shares | +0.80 ppfrom 9.60% | Jan 31, 2025 | SEC |
| Feb 7, 202510:06 AM ET | FMR LLCand 1 other | 13G/A | 9.60%8.90M shares | – | Dec 31, 2024 | SEC |
| Jan 30, 20259:33 PM ET | Vanguard Group Inc | 13G/A | 9.80%9.09M shares | – | Dec 31, 2024 | SEC |
| Apr 26, 2022 | Perceptive Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Apr 21, 2022 | Perceptive Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Deep Track Capital, LP | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Vivo Capital VIII, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Versant Venture Capital V, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | OrbiMed Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Struthers Richard Scott | 13G/AOld format | – | – | – | SEC |
| Feb 3, 20224:41 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 10, 2022 | Driehaus Capital Management LLC | 13GOld format | – | New | – | SEC |
| Jan 10, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Oct 29, 2021 | Biotechnology Value Fund L P | 13GOld format | – | New | – | SEC |
| Apr 22, 2021 | Deep Track Capital, LP | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Versant Venture Capital V, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | 5AM Ventures IV, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Vivo Capital VIII, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | OrbiMed Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 5, 2021 | Struthers Richard Scott | 13G/AOld format | – | – | – | SEC |
| Feb 2, 20213:13 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Crinetics Pharmaceuticals, Inc. shares.
No Form 144 notices for Crinetics Pharmaceuticals, Inc. are on file.